Rapid Review Quiz: Continuous Glucose Monitoring Devices

Romesh Khardori, MD, PhD


May 31, 2023

A recent systematic review determined that CGM proved superior to SMBG in the management of dysglycemia in pregnant women with gestational diabetes. CGM also detected hyper- and hypoglycemic events more effectively and was a more appropriate predictor of qualification for insulin therapy. The researchers concluded that CGM should play an important role in glycemia management for pregnant patients with gestational diabetes.

Limited evidence is available for the changes to assessed neonatal outcomes, including incidence of lower birth weight and large-for-gestational-age. Furthermore, although improved management of dysglycemia may empower better patient compliance, the role of CGM in changing patient health behavior patterns remains to be proven.

Learn more about diabetes and pregnancy.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.